Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous menstrual blood-derived stem cells
- Development stage
- Unknown
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intrauterine (local Injection Into Uterine Cavity)[1][3], Intravenous (in Some Experimental Protocols)
01
Overview
Autologous menstrual blood-derived stem cells (MenSCs) are a type of mesenchymal stem cell isolated from the menstrual blood of the same individual. These cells possess multipotent differentiation potential and exhibit properties such as immunomodulation, anti-inflammatory effects, and tissue regeneration. MenSCs have been investigated primarily for their ability to repair or regenerate endometrial tissue in conditions like intrauterine adhesions (Asherman syndrome) and thin endometrium. Clinical studies have shown that transplantation of autologous MenSCs can improve endometrial thickness and function, thereby enhancing fertility outcomes in women with refractory uterine conditions[1][3][8][10]. The mechanism is believed to involve paracrine signaling that promotes angiogenesis, reduces fibrosis, and stimulates endogenous cell proliferation.
- Other names
- 自体经血干细胞menstrual blood-derived mesenchymal stem cellsMenSCs
Beyond the preview
Go deeper on autologous menstrual blood-derived stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous menstrual blood-derived stem cells.